| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 548 | 9.576 | 14.085 | 21.441 |
| Total Income - EUR | - | - | - | - | - | - | 12.641 | 46.020 | 39.684 | 27.323 |
| Total Expenses - EUR | - | - | - | - | - | - | 15.632 | 48.184 | 47.356 | 37.798 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -2.991 | -2.164 | -7.672 | -10.475 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -2.991 | -2.164 | -7.712 | -11.118 |
| Employees | - | - | - | - | - | - | 3 | 4 | 4 | 3 |
Check the financial reports for the company - Kineto Oxymed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 22.403 | 27.834 | 25.771 | 21.238 |
| Current Assets | - | - | - | - | - | - | 64.924 | 15.531 | 2.696 | 1.998 |
| Inventories | - | - | - | - | - | - | 3.130 | 0 | 1.099 | 786 |
| Receivables | - | - | - | - | - | - | 47.322 | 10.693 | 618 | 614 |
| Cash | - | - | - | - | - | - | 14.473 | 4.838 | 979 | 597 |
| Shareholders Funds | - | - | - | - | - | - | -2.951 | -5.124 | -12.820 | -23.866 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 8.942 | 3.344 | 17.908 | 28.243 |
| Income in Advance | - | - | - | - | - | - | 81.337 | 45.145 | 23.379 | 18.859 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Kineto Oxymed S.r.l.